Aurora Cannabis (ACB)
(Delayed Data from NSDQ)
$7.36 USD
-1.87 (-20.26%)
Updated May 1, 2024 04:00 PM ET
After-Market: $7.33 -0.03 (-0.41%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Price, Consensus and EPS Surprise
ACB 7.36 -1.87(-20.26%)
Will ACB be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for ACB based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ACB
Aurora Cannabis (ACB) Moves 46.0% Higher: Will This Strength Last?
Has Adverum Biotechnologies (ADVM) Outpaced Other Medical Stocks This Year?
ACB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Aurora Cannabis Inc. (ACB) Suffers a Larger Drop Than the General Market: Key Insights
Aurora Cannabis Inc. (ACB) Reports Q3 Loss, Tops Revenue Estimates
Are Medical Stocks Lagging Adicet Bio (ACET) This Year?
Other News for ACB
Pot stocks rally snuffed day after DEA marijuana rescheduling development
Cannabis Stocks CGC, ACB, TLRY Drop After Huge Rescheduling Rally
Canopy Growth Stock: Expect A Crash After The High
OMB review of cannabis rescheduling could put measure at risk
Aurora Cannabis Announces Auditor Change